FIELD: medicine.
SUBSTANCE: the present innovation deals with ways to treat patients with increased risk for development of the above-mentioned diseases. Also, this innovation deals with ways to study or test pharmaceutical preparations or genetic ones applied to treat such diseases by applying animal model including transgenic animal. Methods are based upon polymorphic substitution of leucine for proline in the 7th position in composition of neuropeptide-Y preprosequence gene.
EFFECT: higher efficiency of diagnostics.
13 cl,5 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING RISK OF DIABETIC RETINOPATHY DEVELOPMENT IN CASE OF TYPE 2 DIABETES MELLITUS IN YAKUTS | 2010 |
|
RU2430361C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING DAIBETIC RETINOPATHY ACCOMPANYING TYPE 2 DIABETES MELLITUS IN YAKUT FEMALES | 2011 |
|
RU2461005C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING DIABETIC RETINOPATHY ACCOMPANYING TYPE 2 DIABETES MELLITUS IN YAKUTS | 2011 |
|
RU2473091C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING DAIBETIC RETINOPATHY ACCOMPANYING TYPE 2 DIABETES MELLITUS IN YAKUTS | 2011 |
|
RU2465598C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING DIABETIC RETINOPATHY ACCOMPANYING TYPE 2 DIABETES MELLITUS IN YAKUT MALES | 2011 |
|
RU2473092C1 |
| METHOD OF EARLY PREDICTION OF RISK OF DEVELOPMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2812643C2 |
| METHOD FOR EARLY PREDICTION OF THE RISK OF DEVELOPMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 1 DIABETES MELLITUS | 2022 |
|
RU2793531C1 |
| METHOD FOR ASSESSING THE RISK OF DEVELOPING ATHEROSCLEROSIS BASED ON ANALYSIS OF IMMUNOLOGICAL PARAMETERS | 2018 |
|
RU2704959C1 |
| METHOD FOR PREDICTION OF ATHEROSCLEROSIS DEVELOPMENT | 2018 |
|
RU2704960C1 |
| METHOD FOR PREDICTION OF MULTIFOCAL ATHEROSCLEROTIC INVOLVEMENT | 2018 |
|
RU2704224C1 |
